FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Advanced Pharma NitroGlycerin Recall

NitroGlycerin (2 mg/10 mL in 5% Dextrose Inj, USP QS 10mL (200 mcg per mL), 10 mL Steri…

Advanced Pharma Inc. · Houston, TX

Risk level
Class II
Reported by FDA
Dec 27, 2017
Recall ID
D-0119-2018
Check your lot numberHow we source this data

Summary

Advanced Pharma recalled NitroGlycerin starting Jun 9, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0119-2018 on Dec 27, 2017. Reason: Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system. Status: Terminated.

Why it was recalled

Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

Product description

NitroGlycerin (2 mg/10 mL in 5% Dextrose Inj, USP QS 10mL (200 mcg per mL), 10 mL Sterile single dose syringe, packaged in 5 x 5 (TWENTY FIVE) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054, NDC 15082-863-61.

Lot numbers, UPCs & expiration codes

Lot: 4/20/17 0307 265-86361S, BUD 6/19/17; 4/26/17 0732 265-86361S, BUD 6/25/17; 4/28/17 0215 265-86361S, BUD 6/27/17; 5/2/17 0310 248-86361S, BUD 7/1/17; 5/4/17 1422 248-86361S, BUD 7/3/17; 5/12/17 0841 248-86361S, BUD 7/11/17; 5/18/17 0206 250-86361S, BUD 7/17/17

Where it was sold

Nationwide in the USA to hospitals and medical facilities.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0119-2018
Classification
Class II
Status
Terminated
Recall initiated
Jun 9, 2017
FDA report date
Dec 27, 2017
Quantity
550 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Advanced Pharma Inc.

Original FDA data

Every field from FDA enforcement report D-0119-2018, exactly as published.

Show all FDA fields
City
Houston
State
TX
Status
Terminated
Country
United States
Event ID
77503
Address
9265 Kirby Dr
Code information
Lot: 4/20/17 0307 265-86361S, BUD 6/19/17; 4/26/17 0732 265-86361S, BUD 6/25/17; 4/28/17 0215 265-86361S, BUD 6/27/17; 5/2/17 0310 248-86361S, BUD 7/1/17; 5/4/17 1422 248-86361S, BUD 7/3/17; 5/12/17 0841 248-86361S, BUD 7/11/17; 5/18/17 0206 250-86361S, BUD 7/17/17
Postal code
77054-2520
Report date
Dec 27, 2017
Product type
Drugs
Recall number
D-0119-2018
Classification
Class II
Recalling firm
Advanced Pharma Inc.
Product quantity
550 syringes
Termination date
Apr 3, 2019
Reason for recall
Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.
Voluntary / mandated
Voluntary: Firm initiated
Product description
NitroGlycerin (2 mg/10 mL in 5% Dextrose Inj, USP QS 10mL (200 mcg per mL), 10 mL Sterile single dose syringe, packaged in 5 x 5 (TWENTY FIVE) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054, NDC 15082-863-61.
Distribution pattern
Nationwide in the USA to hospitals and medical facilities.
Recall initiation date
Jun 9, 2017
Initial firm notification
Letter
Center classification date
Dec 20, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0119-2018, published Dec 27, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls